A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid the company's stock having an underwhelming performance in 2025.
The Federal Reserve is about to get a new Federal Reserve Chairman. After a year of criticism, President Trump has nominated long-time Wall Street insider and former Fed Reserve GovernorKevin Warsh to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results